Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156931 | 12615693 | 1 | I | 1999 | 20160725 | 20160802 | 20160802 | EXP | US-ASTRAZENECA-2016SE81724 | ASTRAZENECA | 21.00 | YR | M | Y | 68.50000 | KG | 20160802 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156931 | 12615693 | 1 | PS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | DOSE RANGED FROM 800 TO 900 MG | U | 22047 | PROLONGED-RELEASE TABLET | ||||||||
| 126156931 | 12615693 | 2 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | 22047 | 900 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 126156931 | 12615693 | 3 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | 22047 | 900 | MG | PROLONGED-RELEASE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126156931 | 12615693 | 1 | Schizophrenia |
| 126156931 | 12615693 | 2 | Schizophrenia |
| 126156931 | 12615693 | 3 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126156931 | 12615693 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126156931 | 12615693 | Abdominal pain upper | |
| 126156931 | 12615693 | Dyspnoea | |
| 126156931 | 12615693 | Hunger | |
| 126156931 | 12615693 | Insomnia | |
| 126156931 | 12615693 | Intentional product misuse | |
| 126156931 | 12615693 | Intraocular pressure increased | |
| 126156931 | 12615693 | Large intestine perforation | |
| 126156931 | 12615693 | Memory impairment | |
| 126156931 | 12615693 | Mood swings | |
| 126156931 | 12615693 | Muscle disorder | |
| 126156931 | 12615693 | Off label use | |
| 126156931 | 12615693 | Paranoia | |
| 126156931 | 12615693 | Tachyphrenia | |
| 126156931 | 12615693 | Tendon disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126156931 | 12615693 | 1 | 1999 | 2010 | 0 | |
| 126156931 | 12615693 | 2 | 2011 | 0 | ||
| 126156931 | 12615693 | 3 | 201606 | 20160712 | 0 |